{
"NDC": {
"NDCCode": "0002-7717-61",
"PackageDescription": "1 KIT in 1 CARTON (0002-7717-61) * 1 mL in 1 SYRINGE * 2 mL in 1 SYRINGE * 1 mL in 1 SYRINGE (0002-8011-01) * 2 mL in 1 SYRINGE (0002-3116-01) ",
"NDC11Code": "00002-7717-61",
"ProductNDC": "0002-7717",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Omvoh",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Mirikizumab-mrkz",
"DosageFormName": "KIT",
"RouteName": "SUBCUTANEOUS; SUBCUTANEOUS",
"StartMarketingDate": "20250115",
"EndMarketingDate": null,
"MarketingCategoryName": "BLA",
"ApplicationNumber": "BLA761279",
"LabelerName": "Eli Lilly and Company",
"SubstanceName": null,
"StrengthNumber": null,
"StrengthUnit": null,
"Pharm_Classes": null,
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-12-19",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250115",
"EndMarketingDatePackage": null,
"SamplePackage": "Y"
}
}